Shares of drug developer Morphic surged 76 per cent to $56.15 premarket on Lilly's offer of $57 per share, which represents a 79 per cent premium to stock's last closing price.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/59iGPZm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment